This brochure by Ace Therapeutics offers a comprehensive presentation of our core technical strengths and outlines our commitment to shaping the future of psychiatric disorder research. We are dedicated to supporting pharmaceutical companies and research institutions in accelerating therapeutic innovation and improving research productivity through strategic collaboration.
Our Capabilities
Advanced Technology Platform
Ace Therapeutics utilizes advanced platform to help clients deliver data-rich insights in preclinical psychiatric studies.
Ace Therapeutics offers a diverse portfolio of rodent models and services for depression research.
The PCP-induced model uses NMDA antagonist PCP to mimic core schizophrenia symptoms in animals, studying disease mechanisms and treatments.
The Sucrose Preference Test (SPT) quantifies anhedonia, a core depression-related behavior in mice, by measuring reduced consumption of sucrose solution versus water.
Enter your E-mail and receive the latest news from us